Literature DB >> 28860269

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.

Simon L F Walsh1, Toby M Maher2, Martin Kolb3, Venerino Poletti4,5, Richard Nusser6, Luca Richeldi7, Carlo Vancheri8, Margaret L Wilsher9, Katerina M Antoniou10, Jüergen Behr11, Elisabeth Bendstrup5, Kevin Brown12, Lucio Calandriello13, Tamera J Corte14, Vincent Cottin15, Bruno Crestani16, Kevin Flaherty17, Ian Glaspole18, Jan Grutters19, Yoshikazu Inoue20, Maria Kokosi21, Yasuhiro Kondoh22, Vasileios Kouranos21, Michael Kreuter23, Kerri Johannson24, Eoin Judge25, Brett Ley26, George Margaritopoulos21, Fernando J Martinez27, Maria Molina-Molina28, António Morais29, Hilario Nunes30, Ganesh Raghu31, Christopher J Ryerson32, Moises Selman33, Paolo Spagnolo34, Hiroyuki Taniguchi22, Sara Tomassetti4, Dominique Valeyre30, Marlies Wijsenbeek35, Wim Wuyts36, David Hansell37, Athol Wells38.   

Abstract

We conducted an international study of idiopathic pulmonary fibrosis (IPF) diagnosis among a large group of physicians and compared their diagnostic performance to a panel of IPF experts.A total of 1141 respiratory physicians and 34 IPF experts participated. Participants evaluated 60 cases of interstitial lung disease (ILD) without interdisciplinary consultation. Diagnostic agreement was measured using the weighted kappa coefficient (κw). Prognostic discrimination between IPF and other ILDs was used to validate diagnostic accuracy for first-choice diagnoses of IPF and were compared using the C-index.A total of 404 physicians completed the study. Agreement for IPF diagnosis was higher among expert physicians (κw=0.65, IQR 0.53-0.72, p<0.0001) than academic physicians (κw=0.56, IQR 0.45-0.65, p<0.0001) or physicians with access to multidisciplinary team (MDT) meetings (κw=0.54, IQR 0.45-0.64, p<0.0001). The prognostic accuracy of academic physicians with >20 years of experience (C-index=0.72, IQR 0.0-0.73, p=0.229) and non-university hospital physicians with more than 20 years of experience, attending weekly MDT meetings (C-index=0.72, IQR 0.70-0.72, p=0.052), did not differ significantly (p=0.229 and p=0.052 respectively) from the expert panel (C-index=0.74 IQR 0.72-0.75).Experienced respiratory physicians at university-based institutions diagnose IPF with similar prognostic accuracy to IPF experts. Regular MDT meeting attendance improves the prognostic accuracy of experienced non-university practitioners to levels achieved by IPF experts.
Copyright ©ERS 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28860269     DOI: 10.1183/13993003.00936-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  25 in total

1.  Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis.

Authors:  M Thomeer; M Demedts; J Behr; R Buhl; U Costabel; C D R Flower; J Verschakelen; F Laurent; A G Nicholson; E K Verbeken; F Capron; M Sardina; G Corvasce; I Lankhorst
Journal:  Eur Respir J       Date:  2007-12-05       Impact factor: 16.671

Review 2.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

Review 3.  Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.

Authors:  John Hutchinson; Andrew Fogarty; Richard Hubbard; Tricia McKeever
Journal:  Eur Respir J       Date:  2015-05-14       Impact factor: 16.671

Review 4.  Idiopathic pulmonary fibrosis: diagnosis and epidemiology.

Authors:  Amy L Olson; Jeffrey J Swigris
Journal:  Clin Chest Med       Date:  2012-03       Impact factor: 2.878

5.  Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK.

Authors:  J Gribbin; R B Hubbard; I Le Jeune; C J P Smith; J West; L J Tata
Journal:  Thorax       Date:  2006-07-14       Impact factor: 9.139

6.  Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?

Authors:  Kevin R Flaherty; Talmadge E King; Ganesh Raghu; Joseph P Lynch; Thomas V Colby; William D Travis; Barry H Gross; Ella A Kazerooni; Galen B Toews; Qi Long; Susan Murray; Vibha N Lama; Steven E Gay; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2004-07-15       Impact factor: 21.405

7.  Clinical impact of the interstitial lung disease multidisciplinary service.

Authors:  Helen E Jo; Ian N Glaspole; Kovi C Levin; Samuel R McCormack; Annabelle M Mahar; Wendy A Cooper; Rhoda Cameron; Samantha J Ellis; Alice M Cottee; Susanne E Webster; Lauren K Troy; Paul J Torzillo; Peter Corte; Karen M Symons; Nicole Taylor; Tamera J Corte
Journal:  Respirology       Date:  2016-07-18       Impact factor: 6.424

8.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

9.  The increasing secondary care burden of idiopathic pulmonary fibrosis: hospital admission trends in England from 1998 to 2010.

Authors:  Vidya Navaratnam; Andrew W Fogarty; Rachel Glendening; Tricia McKeever; Richard B Hubbard
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

10.  Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century.

Authors:  John P Hutchinson; Tricia M McKeever; Andrew W Fogarty; Vidya Navaratnam; Richard B Hubbard
Journal:  Ann Am Thorac Soc       Date:  2014-10
View more
  17 in total

1.  Impact of an interstitial lung disease service in the diagnosis and management of interstitial lung disease in Singapore.

Authors:  Gin Tsen Chai; Teck Choon Tan; Yeong Shyan Lee; Gregory Jl Kaw; Khoon Leong Chuah; Yi Jing Lim; John Arputhan Abisheganaden; Bernard Yh Thong
Journal:  Singapore Med J       Date:  2019-07-11       Impact factor: 1.858

2.  [Chronic fibrosing lung diseases : Idiopathic pulmonary fibrosis from the perspective of its differential diagnosis].

Authors:  R C Dartsch; L Fink; A Breithecker; P Markart; S Tello; W Seeger; A Günther
Journal:  Internist (Berl)       Date:  2019-04       Impact factor: 0.743

3.  Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.

Authors:  Michael Kreuter; Jeff Swigris; David Pittrow; Silke Geier; Jens Klotsche; Antje Prasse; Hubert Wirtz; Dirk Koschel; Stefan Andreas; Martin Claussen; Christian Grohé; Henrike Wilkens; Lars Hagmeyer; Dirk Skowasch; Joachim F Meyer; Joachim Kirschner; Sven Gläser; Felix J F Herth; Tobias Welte; Claus Neurohr; Martin Schwaiblmair; Matthias Held; Thomas Bahmer; Marion Frankenberger; Jürgen Behr
Journal:  Respir Res       Date:  2017-07-14

4.  The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.

Authors:  Andreas Guenther; Ekaterina Krauss; Silke Tello; Jasmin Wagner; Bettina Paul; Stefan Kuhn; Olga Maurer; Sabine Heinemann; Ulrich Costabel; María Asunción Nieto Barbero; Veronika Müller; Philippe Bonniaud; Carlo Vancheri; Athol Wells; Martina Vasakova; Alberto Pesci; Matteo Sofia; Walter Klepetko; Werner Seeger; Fotios Drakopanagiotakis; Bruno Crestani
Journal:  Respir Res       Date:  2018-07-28

5.  Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.

Authors:  Joo Heung Yoon; Mehdi Nouraie; Xiaoping Chen; Richard H Zou; Jacobo Sellares; Kristen L Veraldi; Jared Chiarchiaro; Kathleen Lindell; David O Wilson; Naftali Kaminski; Timothy Burns; Humberto Trejo Bittar; Samuel Yousem; Kevin Gibson; Daniel J Kass
Journal:  Respir Res       Date:  2018-10-03

Review 6.  Idiopathic pulmonary fibrosis: the radiologist's role in making the diagnosis.

Authors:  Michael P Mohning; John Caleb Richards; Tristan J Huie
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

7.  Idiopathic pulmonary fibrosis: Educational needs of health-care providers, patients, and caregivers.

Authors:  Deepa Ramadurai; Stephanie Corder; Tara Churney; Bridget Graney; Andrea Harshman; Sarah Meadows; Jeffrey J Swigris
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

8.  The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the Current Evidence and Future Perspectives.

Authors:  Federica Furini; Aldo Carnevale; Gian Luca Casoni; Giulio Guerrini; Lorenzo Cavagna; Marcello Govoni; Carlo Alberto Sciré
Journal:  Front Med (Lausanne)       Date:  2019-10-31

9.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

Review 10.  Diagnosis of Idiopathic Pulmonary Fibrosis: Differential Diagnosis.

Authors:  Myriam Aburto; Inmaculada Herráez; David Iturbe; Ana Jiménez-Romero
Journal:  Med Sci (Basel)       Date:  2018-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.